Form 8-K · Current report
GE HealthCare 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0001932393
- Accession no.
- 0001932393-26-000047
Summary
GE HealthCare combined its Imaging and Advanced Visualization Solutions businesses into a new reportable segment, Advanced Imaging Solutions, as part of a second-quarter 2026 leadership and organizational change, leaving the company with three reportable segments: AIS, Pharmaceutical Diagnostics, and Patient Care Solutions. The company filed recast unaudited historical financial information to reflect the new structure, saying it has no impact on previously reported financial statements.
Key points
- The new Advanced Imaging Solutions segment covers Radiology (formerly the Imaging business) plus Specialized Ultrasound and Procedural Guidance, which were previously reported in the AVS business.
- GE HealthCare's PDx and PCS segments continue to operate as described in its Form 10-K for the fiscal year ended December 31, 2025.
- The company furnished recast unaudited historical financial information as Exhibit 99 to aid comparability, stating it has no impact on previously reported financial statements for any period.
- The information furnished under Item 7.01 is not deemed filed under Section 18 of the Exchange Act.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD Disclosure. GE HealthCare Technologies Inc. ("GE HealthCare," the “Company,” “our,” “us,” or “we”) is filing this Current Report on Form 8-K to provide recast unaudited historical financial information related to a previously announced change in reportable segments. In the second quarter of 2026, we made a strategic change to our executive leadership and to our segments, combining our Imaging and Advanced Visualization Solutions businesses into a new operating and reportable segment, Advanced Imaging Solutions (“AIS”). This change positions the Company to enhance execution, accelerate innovation, and create efficiencies. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.